Reset
Showing 1 of 1 academic articles

Outcomes of primary gastrointestinal diffuse large B cell lymphoma in the rituximab era

Luyao Zhang, Jianwen Zhou, Yanyan Sun, Yaodong Zhang et al. • Discover Oncology (2026)

Abstract Background Primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL) constitutes 30%-40% of primary extranodal lymphomas. While rituximab has significantly improved survival in nodal DLBCL, its impact on the prognosis of P...

DOAJ Open Access (DOAJ) DOI: 10.1007/s12672-026-05022-z